Padua Prediction Score

Estimates VTE risk in hospitalized medical patients

Low risk of VTE

Tap to see more

Active cancer

Patients with local or distant metastases and/or in whom chemotherapy or radiotherapy had been performed in the previous 6 months.

Previous VTE (with the exclusion of superficial vein thrombosis)

Reduced mobility

Bedrest with bathroom privileges (either due to patient's limitations or on physicians order) for at least 3 days.

Already known thrombophilic condition

Carriage of defects of antithrombin, protein C or S, factor V Leiden, G20210A prothrombin mutation, antiphospholipid syndrome.

Recent (≤ 1 month) trauma and/or surgery

Elderly age (≥ 70 years)

Heart and/or respiratory failure

Acute myocardial infarction or ischemic stroke

Acute infection and/or rheumatologic disorder

Obesity (BMI ≥ 30)

Ongoing hormonal treatment

Dodatne informacije

Odštampajte ili sačuvajte kao PDF

Povratne informacije o alatu

Uputstva i reference

Upozorenje

Ova alatka služi isključivo u obrazovne svrhe i ne predstavlja profesionalni savet niti zamenu za profesionalni savet. Alatku ne treba koristiti za postavljanje medicinske dijagnoze i/ili pružanje medicinske terapije.

Opšti opis
Padova skor venske tromboembolije (VTE) procenjuje rizik od VTE kod hospitalizovanih pacijenata. On izračunava ocenu rizika na osnovu 11 uobičajenih faktora rizika za VTE kod hospitalizovanih pacijenata. Pacijenti su stratifikovani u grupe visokog rizika (≥ 4 poena) i grupe niskog rizika (< 4 poena).

Reference values

Low risk of VTE

< 4

High risk of VTE

≥ 4

Scoring

Active cancer (+3 points)

Previous VTE (excluding superficial vein thrombosis) (+3 points)

Reduced Mobility (+3 points)

Already known thrombophilic condition (+3 points)

Recent (≤ 1 month) trauma and/or surgery (+2 points)

Elderly Age (≥ 70 years) (+1 point)

Heart and/or respiratory failure (+1 point)

Acute MI and/or Ischemic Stroke (+1 point)

Acute infection and/or rheumatologic disorder (+1 point)

Obesity (BMI ≥ 30) (+1 point)

Ongoing hormonal treatment (+1 point)

References

Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010 Nov;8(11):2450-7.

Kahn SR, Lim W, Dunn AS, et al. American College of Chest Physicians Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):195S–226S.

Verzija

Više o ovoj alatki

Padova skor venske tromboembolije (VTE) procenjuje rizik od VTE kod hospitalizovanih pacijenata. On izračunava ocenu rizika na osnovu 11 uobičajenih faktora rizika za VTE kod hospitalizovanih pacijenata. Pacijenti su stratifikovani u grupe visokog rizika (≥ 4 poena) i grupe niskog rizika (< 4 poena).